Status:
UNKNOWN
The Use of Angiotensin Converting Enzyme Inhibitors and Incident Respiratory Infections, Are They Harmful or Protective?
Lead Sponsor:
University College, London
Conditions:
Covid-19, Coronavirus, Angiotensin Converting Enzyme Inhibitors, Influenza, Electronic Health Records, Epidemiology, Comorbidity, Incidence, United Kingdom
Eligibility:
All Genders
18+ years
Brief Summary
The study use UK based linked electronic health records from the Clinical Research Datalink (CALIBER) of 5.6 million individuals to conduct a matched case-control study to investigate the incidence of...
Eligibility Criteria
Inclusion
- We identify individuals aged 18 years or older and registered in the current primary care practice for at least one year.
Exclusion
- We exclude individuals with a prior history of influenza and viral pneumonia before study entry.
Key Trial Info
Start Date :
January 1 1998
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 31 2021
Estimated Enrollment :
1302508 Patients enrolled
Trial Details
Trial ID
NCT04322786
Start Date
January 1 1998
End Date
March 31 2021
Last Update
November 13 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.